Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, Marinos G, Kaldor JM. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology. 2001;34(4 Pt 1):809–16.
Article
CAS
Google Scholar
Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(5 Suppl 1):S35–50.
Article
Google Scholar
Bruggmann P, Berg T, Ovrehus AL, Moreno C, Brandao Mello CE, Roudot-Thoraval F, Marinho RT, Sherman M, Ryder SD, Sperl J, et al. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat. 2014;21(Suppl 1):5–33.
Article
Google Scholar
Polaris Observatory HCVC. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2(3):161–76.
Article
Google Scholar
Kamal SM. Acute hepatitis C: a systematic review. Am J Gastroenterol. 2008;103(5):1283–97 quiz 1298.
Article
Google Scholar
Kaberg M, Hammarberg A, Lidman C, Weiland O. Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program. Infect Dis (Lond). 2017;49(10):728–36.
Article
Google Scholar
Lidman C, Norden L, Kaberg M, Kall K, Franck J, Aleman S, Birk M. Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and gender. Scand J Infect Dis. 2009;41(9):679–84.
Article
Google Scholar
Martin NK, Vickerman P, Grebely J, Hellard M, Hutchinson SJ, Lima VD, Foster GR, Dillon JF, Goldberg DJ, Dore GJ, et al. Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals. Hepatology. 2013;58(5):1598–609.
Article
CAS
Google Scholar
Prisons and Health. http://www.euro.who.int/__data/assets/pdf_file/0005/249188/Prisons-and-Health.pdf. Accessed 2 Apr 2019.
Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H, Rich JD, van den Bergh BJ, Degenhardt L. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology. 2013;58(4):1215–24.
Article
Google Scholar
Zampino R, Coppola N, Sagnelli C, Di Caprio G, Sagnelli E. Hepatitis C virus infection and prisoners: epidemiology, outcome and treatment. World J Hepatol. 2015;7(21):2323–30.
Article
Google Scholar
Brandolini M, Novati S, De Silvestri A, Tinelli C, Patruno SF, Ranieri R, Seminari E. Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting. BMC Public Health. 2013;13:981.
Article
Google Scholar
Mohamed HI, Saad ZM, Abd-Elreheem EM, Abd-ElGhany WM, Mohamed MS, Abd Elnaeem EA, Seedhom AE. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases. J Infect Public Health. 2013;6(3):186–95.
Article
Google Scholar
Barros LA, Pessoni GC, Teles SA, Souza SM, Matos MA, Martins RM, Del-Rios NH, Matos MA, Carneiro MA. Epidemiology of the viral hepatitis B and C in female prisoners of metropolitan regional prison complex in the state of Goias, Central Brazil. Rev Soc Bras Med Trop. 2013;46(1):24–9.
Article
Google Scholar
Treso B, Barcsay E, Tarjan A, Horvath G, Dencs A, Hettmann A, Csepai MM, Gyori Z, Rusvai E, Takacs M. Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary. J Urban Health. 2012;89(1):108–16.
Article
Google Scholar
Saiz de la Hoya P, Marco A, Garcia-Guerrero J, Rivera A. Prevalhep study g: Hepatitis C and B prevalence in Spanish prisons. Eur J Clin Microbiol Infect Dis. 2011;30(7):857–62.
Article
CAS
Google Scholar
Jacomet C, Guyot-Lenat A, Bonny C, Henquell C, Rude M, Dydymski S, Lesturgeon JA, Lambert C, Pereira B, Schmidt J. Addressing the challenges of chronic viral infections and addiction in prisons: the PRODEPIST study. Eur J Pub Health. 2016;26(1):122–8.
Article
Google Scholar
Puga MA, Bandeira LM, Pompilio MA, Croda J, Rezende GR, Dorisbor LF, Tanaka TS, Cesar GA, Teles SA, Simionatto S, et al. Prevalence and incidence of HCV infection among prisoners in Central Brazil. PLoS One. 2017;12(1):e0169195.
Article
Google Scholar
Morey S, Hamoodi A, Jones D, Young T, Thompson C, Dhuny J, Buchanan E, Miller C, Hewett M, Valappil M, et al. Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine. J Viral Hepat. 2019;26(1):101–8.
Article
Google Scholar
Jacob Søholm BM, Holm DK. Peer Brehm Christensen: Blood borne viral infections, liver fibrosis and drug habits in a Danish prison population In: EASL The International Liver Congress 2018. Paris: France; 2018.
Google Scholar
Bartlett SR, Fox P, Cabatingan H, Jaros A, Gorton C, Lewis R, Priscott E, Dore GJ, Russell DB. Demonstration of near-elimination of hepatitis C virus among a prison population: the Lotus Glen correctional Centre hepatitis C treatment project. Clin Infect Dis. 2018;67(3):460–3.
Article
Google Scholar
Assoumou SA, Wang J, Tasillo A, Eftekhari Yazdi G, Tsui JI, Strick L, Linas BP. Hepatitis C testing and patient characteristics in Washington State's prisons between 2012 and 2016. Am J Prev Med. 2019;56(1):8–16.
Article
Google Scholar
Kriminalvård och statistik 2017. https://www.kriminalvarden.se/globalassets/forskning_statistik/kos-2017-kriminalvard-och-statistik.pdf. Accessed 28 Mar 2019.
Riskbeteenden, hiv och hepatit bland personer som injicerade droger i Stockholm 1987–1998. https://www.folkhalsomyndigheten.se/contentassets/68d426c2131e4b15ae5c220829ea21d4/riskbeteenden-hiv-hepatit-bland-personer-injicerade-droger-1987-1998_15040-webb.pdf. Accessed 2 Apr 2019.
Behandling för hepatit C på anstalt. https://www.lakemedelsvarlden.se/behandling-for-hepatit-c-pa-anstalt/. Accessed 3 Apr 2019.
Mina MM, Herawati L, Butler T, Lloyd A. Hepatitis C in Australian prisons: a national needs assessment. Int J Prison Health. 2016;12(1):3–16.
Article
Google Scholar
Dumont DM, Brockmann B, Dickman S, Alexander N, Rich JD. Public health and the epidemic of incarceration. Annu Rev Public Health. 2012;33:325–39.
Article
Google Scholar
Pawlotsky J-M, Negro F, Aghemo A, Berenguer M, Dalgard O, Dusheiko G, Marra F, Puoti M, Wedemeyer H. EASL recommendations on treatment of hepatitis C 2018. J Hepatol. 2018;69(2):461–511.
Article
Google Scholar
Recommendations for testing, managing, and treating hepatitis C. http://www.hcvguidelines.org. Accessed 7 July 2019.
Hu Y-C, Yeh C-C, Chen R-Y, Su C-T, Wang W-C, Bai C-H, Chan C-F, Su FH. Seroprevalence of hepatitis B virus in Taiwan 30 years after the commencement of the national vaccination program. PeerJ. 2018;6:e4297.
Article
Google Scholar
Rekommendationer om vaccination mot hepatit B. https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/r/rekommendationer-om-vaccination-mot-hepatit-b-/?
Turner KM, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, May M, Taylor A, De Angelis D, Cameron S, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011;106(11):1978–88.
Article
Google Scholar
Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, Courtney R, McKee M, Amon JJ, Maher L, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388(10049):1089–102.
Article
Google Scholar
Vescio MF, Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, Monarca R. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health. 2008;62(4):305–13.
Article
CAS
Google Scholar
Kivimets K, Uuskula A, Lazarus JV, Ott K. Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015. BMC Infect Dis. 2018;18(1):339.
Article
Google Scholar
Tassiopoulos K, Bernstein J, Bernstein E. Age and sharing of needle injection equipment in a cohort of Massachusetts injection drug users: an observational study. Addict Sci Clin Pract. 2013;8(1):20.
Article
Google Scholar
Hoffmann G, Berglund G, Elmstahl S, Eriksson S, Verbaan H, Widell A, Lindgren S. Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged Swedish general urban population. Scand J Gastroenterol. 2000;35(8):861–5.
Article
CAS
Google Scholar
Hiv idag. https://www.folkhalsomyndigheten.se/hividag/om-hiv/. Accessed 2 Apr 2019.
Gilbert RL, Costella A, Piper M, Gill ON. Increasing hepatitis B vaccine coverage in prisons in England and Wales. Commun Dis Public Health. 2004;7(4):306–11.
CAS
PubMed
Google Scholar
Palmateer NE, Goldberg DJ, Munro A, Taylor A, Yeung A, Wallace LA, Mitchell A, Shepherd SJ, Gunson RN, Aitken C, et al. Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs. Addiction. 2018;113(1):80–90.
Article
Google Scholar
Kriminalvård och statistik 2018. https://www.kriminalvarden.se/globalassets/publikationer/kartlaggningar-och-utvarderingar/kos-2018.pdf. Accessed 10 Aug 2019.
Vroling H, Oordt-Speets AM, Madeddu G, Babudieri S, Monarca R, O'Moore E, Vonk Noordegraaf-Schouten M, Wolff H, Montanari M, Hedrich D, et al. A systematic review on models of care effectiveness and barriers to hepatitis C treatment in prison settings in the EU/EEA. J Viral Hepat. 2018;25(12):1406–22.
Article
Google Scholar
Nationella Programområden. https://skl.se/halsasjukvard/kunskapsstodvardochbehandling/systemforkunskapsstyrning/nationellaprogramomraden.1814.html. Accessed 7 July 2019.
Tavoschi L, Vroling H, Madeddu G, Babudieri S, Monarca R, Vonk Noordegraaf-Schouten M, Beer N, Gomes Dias J, O’Moore É, Hedrich D, et al. Active case finding for communicable diseases in prison settings: increasing testing coverage and uptake among the prison population in the European Union/European economic area. Epidemiol Rev. 2018;40(1):105–20.
Article
Google Scholar
de la Flor C, Porsa E, Nijhawan AE. Opt-out HIV and hepatitis C testing at the Dallas County jail: uptake, prevalence, and demographic characteristics of testers. Public Health Rep. 2017;132(6):617–21.
Article
Google Scholar
Lara B, Strick MD. HIV screening of male inmates during prison intake medical evaluation--Washington, 2006-2010. MMWR Morb Mortal Wkly Rep. 2011;60(24):811–3.
Centers for disease control and prevention. Revised CDC recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings: annotated guide. 2010.
Bielen R, Stumo SR, Halford R, Werling K, Reic T, Stöver H, Robaeys G, Lazarus JV. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries. Harm Reduct J. 2018;15(1):25.
Article
Google Scholar